Search results
Results from the WOW.Com Content Network
Post herniorrhaphy pain syndrome, or inguinodynia is pain or discomfort lasting greater than 3 months after surgery of inguinal hernia. Randomized trials of laparoscopic vs open inguinal hernia repair have demonstrated similar recurrence rates with the use of mesh and have identified that chronic groin pain (>10%) surpasses recurrence (<2%) and is an important measure of success.
Hernia surgery is one of the most common current applications of surgical mesh. Hernias occur when organs or fatty tissue bulge through openings or debilitated areas of muscle, usually in the abdominal wall. Surgical mesh is implanted to strengthen tissue repair and minimize the rate of recurrence.
Shirin Towfigh (born 1971, Tehran) is an American surgeon who specializes in minimally invasive hernia surgery. [1] She is the president and founder of the Beverly Hills Hernia Center, a specialty clinic launched in 2013 for treating hernias and hernia-related complications. [2]
This interactive feature details the fee and cost committee's final written recommendations for dividing up attorney fees and costs for firms involved in the sprawling products liability litigation.
Inguinal hernia surgery is an operation to repair a weakness in the abdominal wall that abnormally allows abdominal contents to slip into a narrow tube called the inguinal canal in the groin region. There are two different clusters of hernia: groin and ventral (abdominal) wall. Groin hernia includes femoral, obturator, and inguinal. [1]
A Texas family is suing a major hospital for giving their 4-year-old what they say is an "unintended vasectomy" during a routine hernia surgery. A lawsuit filed on June 17 in Harris County, Texas ...
Inguinal hernia repair with mesh diagram Laparoscopic hernia repair with mesh. Surgery is recommended for some types of hernias to prevent complications such as obstruction of the bowel or strangulation of the tissue, although umbilical hernias and hiatus hernias may be watched, or are treated with medication. [34]
The French pharmaceutical company Sanofi says it has reached an agreement to resolve 4,000 cases in the U.S., in which plaintiffs are linking the discontinued heartburn drug Zantac — and its ...